治疗肝功能衰竭的生物人工肝系统:一个即将出现的治疗乌托邦

IF 33 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Jingqi Wu, Lijian Hui
{"title":"治疗肝功能衰竭的生物人工肝系统:一个即将出现的治疗乌托邦","authors":"Jingqi Wu, Lijian Hui","doi":"10.1016/j.jhep.2025.10.002","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Uncited reference</h2>[1].</section></section><section><section><h2>Authors’ contributions</h2>Both authors contributed equally to the writing of this editorial.</section></section><section><section><h2>Financial support</h2>This project was supported by the Shanghai Science and Technology Committee (25J32800100).</section></section><section><section><h2>Conflict of interest</h2>L.H. is the founder of Hexaell Biotech, serves as a member of the Board of Directors for the International Society for Stem Cell Research (ISSCR), and is the President of the Chinese Society for Cell and Gene Therapy (CSCGT).Please refer to the accompanying ICMJE disclosure forms for further details.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"11 1","pages":""},"PeriodicalIF":33.0000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bioartificial Liver System for Liver Failure: A Therapeutic UTOpiA on the Horizon\",\"authors\":\"Jingqi Wu, Lijian Hui\",\"doi\":\"10.1016/j.jhep.2025.10.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Uncited reference</h2>[1].</section></section><section><section><h2>Authors’ contributions</h2>Both authors contributed equally to the writing of this editorial.</section></section><section><section><h2>Financial support</h2>This project was supported by the Shanghai Science and Technology Committee (25J32800100).</section></section><section><section><h2>Conflict of interest</h2>L.H. is the founder of Hexaell Biotech, serves as a member of the Board of Directors for the International Society for Stem Cell Research (ISSCR), and is the President of the Chinese Society for Cell and Gene Therapy (CSCGT).Please refer to the accompanying ICMJE disclosure forms for further details.</section></section>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":33.0000,\"publicationDate\":\"2025-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhep.2025.10.002\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.10.002","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

章节片段引用的参考[1]。作者的贡献两位作者对这篇社论的写作贡献相同。上海市科学技术委员会资助项目(25J32800100)。利益冲突;他是Hexaell Biotech的创始人,是国际干细胞研究学会(ISSCR)的董事会成员,也是中国细胞与基因治疗学会(CSCGT)的主席。详情请参阅随附的ICMJE披露表格。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Bioartificial Liver System for Liver Failure: A Therapeutic UTOpiA on the Horizon

Section snippets

Uncited reference

[1].

Authors’ contributions

Both authors contributed equally to the writing of this editorial.

Financial support

This project was supported by the Shanghai Science and Technology Committee (25J32800100).

Conflict of interest

L.H. is the founder of Hexaell Biotech, serves as a member of the Board of Directors for the International Society for Stem Cell Research (ISSCR), and is the President of the Chinese Society for Cell and Gene Therapy (CSCGT).Please refer to the accompanying ICMJE disclosure forms for further details.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Hepatology
Journal of Hepatology 医学-胃肠肝病学
CiteScore
46.10
自引率
4.30%
发文量
2325
审稿时长
30 days
期刊介绍: The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信